Long-term results of endoscopic resection for type i gastric neuroendocrine tumors

Journal of Surgical Oncology

Volumn 109, Issue 2, 2014, Pages 71-74

  Uygun, Ahmet ^a   Kadayifci, Abdurrahman ^b   Polat, Zulfikar ^a   Yilmaz, Kemalettin ^a   Gunal, Armagan ^a   Demir, Hakan ^a   Bagci, Sait ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

endoscopic mucosectomy; gastric carcinoid; neuroendocrine tumors

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ENDOSCOPIC MUCOSAL RESECTION; FEMALE; HUMAN; HUMAN TISSUE; HYPERGASTRINEMIA; INTESTINE METAPLASIA; MALE; MIDDLE AGED; NEUROENDOCRINE TUMOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STOMACH PERFORATION; STOMACH POLYP; SURVIVAL RATE; TERTIARY CARE CENTER; TREATMENT OUTCOME; TUMOR VOLUME; TYPE I GASTRIC NEUROENDOCRINE TUMOR;

ENDOSCOPIC MUCOSECTOMY; GASTRIC CARCINOID; NEUROENDOCRINE TUMORS;

ADULT; AGED; CHROMOGRANIN A; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTRINS; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROENDOCRINE TUMORS; POLYPS; PROSPECTIVE STUDIES; REOPERATION; STOMACH NEOPLASMS;

EID: 84892908735     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23477     Document Type: Article

References (23)

1. Mulkeen A, Cha C:, Gastric carcinoid. Curr Opin Oncol 2004; 17: 1-6.
2. Modlin IM, Moss SF, Oberg K, et al.: Gastrointestinal neuroendocrine (carcinoid) tumours: Current diagnosis and management. Med J Aust 2012; 193: 46-52.
3. Fendrich V, Bartsch DK:, Surgical treatment of gastrointestinal neuroendocrine tumors. Langenhecks Arch Surg 2011; 396: 299-311.
4. Massironi S, Sciola V, Spampatti MP, et al.: Gastric carcinoids: Between underestimation and overtreatment. World J Gastroenterol 2009; 15: 2177-2183.
5. Otani Y, Furukawa T, Suganuma K, et al.: Minimally invasive surgery for gastric carcinoid tumor. Biomed Pharmacother 2002; 56: 217-221.
6. Borch K, Ahrén B, Ahlman H, et al.: Gastric carcinoids: Biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 2005; 242: 64-73.
7. Bektas H, Länger F, Piso P, et al.: Neuroendocrine tumors of the stomach. Surgery therapy and prognosis. Chirurg 2002; 73: 331-335.
8. Ichikawa J, Tanabe S, Koizumi W, et al.: Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 2003; 35: 203-206.
9. Hopper AD, Bourke MJ, Hourigan LF, et al.: En-bloc resection of multiple type 1 gastric carcinoid tumors by endoscopic multi-band mucosectomy. J Gastroenterol Hepatol 2009; 24: 1516-1521.
10. Fykse V, Sandvik AK, Qvigstad G, et al.: Treatment of ECL cell carcinoids with octreotide LAR. Scand J Gastroenterol 2004; 39: 621-628.
11. Fossmark R, Sørdal Ø, Jianu CS, et al.: Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther 2012; 36: 1067-1075.
12. Ravizza D, Fiori G, Trovato C, et al.: Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours. Dig Liver Dis 2007; 39: 537-543.
13. Dekker W, op den Orth JO:, Polyps of the stomach and duodenum: Significance and management. Dig Dis 1992; 10: 199-207.
14. Goddard AF, Badreldin R, Pritchard DM, et al.: The management of gastric polyps. Gut 2010; 59: 1270-1276.
15. Mulkeen A, Cha C:, Gastric carcinoid. Curr Opin Oncol 2005; 17: 1-6.
16. Zhang L, Ozao J, Warner R, et al.: Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor. World J Surg 2011; 35: 1879-1886.
17. Ozao-Choy J, Buch K, Strauchen JA, et al.: Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors. J Surg Res 2010; 162: 22-25.
18. Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al.: ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 2012; 95: 74-87.
19. Schindl M, Kaserer K, Niederle B:, Treatment of gastric neuroendocrine tumors: The necessity of a type-adapted treatment. Arch Surg 2001; 136: 49-54.
20. Gladdy RA, Strong VE, Coit D, et al.: Defining surgical indications for type I gastric carcinoid tumor. Ann Surg Oncol 2009; 16: 3154-3160.
21. Merola E, Sbrozzi-Vanni A, Panzuto F, et al.: Type I gastric carcinoids: A prospective study on endoscopic management and recurrence rate. Neuroendocrinology 2012; 95: 207-213.
22. Karaca C, Turner BG, Cizginer S, et al.: Accuracy of EUS in the evaluation of small gastric subepithelial lesions. Gastrointest Endosc 2010; 71: 722-727.
23. Varas MJ, Gornals JB, Pons C, et al.: Usefulness of endoscopic ultrasonography (EUS) for selecting carcinoid tumors as candidates to endoscopic resection. Rev Esp Enferm Dig 2010; 102: 577-582.